Danaher Corporation vs Merck & Company, Inc. — Stock Comparison
Danaher Corporation (DHR) and Merck & Company, Inc. (MRK) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Danaher Corporation narrowly edges Merck & Company, Inc. on Q·Score (7.7 vs 7 out of 10), led by Health (9.1 vs 7) and Valuation (8.6 vs 6.7). Merck & Company, Inc. scores higher on Quality, reflecting stronger profitability and returns. Analyst consensus targets imply greater upside for DHR (+36.8%) than for MRK (+13.9%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Clean balance sheet with low leverage (0.4× debt-to-equity).
High-quality business with 19% return on equity and 14% profit margins.
Analyst Consensus
Fundamentals
Frequently Asked Questions
DHR vs MRK: which stock scores better overall?
Based on Q·Score, Danaher Corporation (DHR) scores 7.7/10 versus Merck & Company, Inc. (MRK) at 7/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: DHR or MRK?
Danaher Corporation (DHR) scores higher on Growth (6.2/10 vs 6.2/10). Danaher Corporation reports revenue growth (3.7% YoY) while Merck & Company, Inc. reports (4.9% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is DHR or MRK more attractively valued?
Danaher Corporation (DHR) scores higher on Valuation (8.6/10 vs 6.7/10). DHR trades at 19.2× P/E versus MRK at 11.9×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about DHR vs MRK?
There are 23 analysts covering DHR with a consensus price target of $242.35, and 27 analysts covering MRK with a consensus target of $129.74. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: DHR or MRK?
Merck & Company, Inc. (MRK) scores higher on Quality (7.7/10 vs 6.7/10). Net profit margin: DHR at 14.9%, MRK at 13.6%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: DHR or MRK?
Danaher Corporation (DHR) scores higher on Financial Health (9.1/10 vs 7/10). Market beta: DHR at 0.83, MRK at 0.22. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of DHR and MRK?
Danaher Corporation (DHR) has a market capitalisation of $125.4B, while Merck & Company, Inc. (MRK) has a market cap of $281.2B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do DHR or MRK pay dividends?
DHR does not currently pay a dividend, while MRK pays a dividend yield of 2.95%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →